These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33817214)

  • 1. FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis.
    Chen X; Ding L; Kong D; Zhao X; Liao L; Zhang Y; Li F; Liu R
    Open Life Sci; 2020; 15(1):259-266. PubMed ID: 33817214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and significance of caveolin-1 in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng H; Pan Y; Yao Y; Zhu Z; Chen J; Sun X; Qiu Y; Ding Y
    Exp Ther Med; 2017 Nov; 14(5):4356-4362. PubMed ID: 29067114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.
    Ma LN; Liu XY; Lu ZH; Wu LG; Tang YY; Luo X; Hu YC; Yan TT; Wang Q; Ding XC; Xie Y
    Oncol Lett; 2017 May; 13(5):3457-3464. PubMed ID: 28521452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
    Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FXYD6 is a new biomarker of cholangiocarcinoma.
    Chen X; Sun M; Hu Y; Zhang H; Wang Z; Zhou N; Yan X
    Oncol Lett; 2014 Feb; 7(2):393-398. PubMed ID: 24396454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
    Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
    Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating AFP mRNA as a Possible Indicator of Hematogenous Spread of HCC Cells: A Possible Association with HBV Infection.
    Montaser LM; Abbas OM; Saltah AM; Waked IA
    J Egypt Natl Canc Inst; 2007 Mar; 19(1):48-60. PubMed ID: 18839035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
    Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FXYD6: a novel therapeutic target toward hepatocellular carcinoma.
    Gao Q; Chen X; Duan H; Wang Z; Feng J; Yang D; Song L; Zhou N; Yan X
    Protein Cell; 2014 Jul; 5(7):532-43. PubMed ID: 24715268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Non-Coding RNA IGF2AS in Serum may be a Biomarker for Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Qi J; Li J; Sun J; Li C
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-α-induced protein 8-like 2 mRNA in peripheral blood mononuclear cells is associated with the disease progression of chronic hepatitis B virus infection.
    Liu Y; Jin J; Ji J; Gao XM; Fan YC
    Virol J; 2019 Oct; 16(1):120. PubMed ID: 31661000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of murine double minute-2 promoter methylation and serum AFP improves diagnostic efficiency in hepatitis B virus-related hepatocellular carcinoma.
    Wang JW; Qian Y; Wu CS; Zhao NH; Fang Y; Yuan XD; Gao S; Fan YC; Wang K
    Int J Med Sci; 2020; 17(18):3190-3199. PubMed ID: 33173438
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of Long Noncoding RNA SEMA6A-AS1 Expression with Clinical Outcome in HBV-Related Hepatocellular Carcinoma.
    Yu S; Li N; Wang J; Fu Y; Huang Y; Yi P; Chen R; Tang D; Hu X; Fan X
    Clin Ther; 2020 Mar; 42(3):439-447. PubMed ID: 32070484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B Virus X Protein Driven Alpha Fetoprotein Expression to Promote Malignant Behaviors of Normal Liver Cells and Hepatoma Cells.
    Zhu M; Lu Y; Li W; Guo J; Dong X; Lin B; Chen Y; Xie X; Li M
    J Cancer; 2016; 7(8):935-46. PubMed ID: 27313784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predisposing metastatic tumor antigen 1 overexpression in hepatitis B virus associated hepatocellular carcinoma.
    Jin YJ; Chung YH; Kim JA; Park WH; Lee D; Seo DD; Ryu SH; Jang MK; Yu E; Lee YJ
    Dig Dis Sci; 2012 Nov; 57(11):2917-23. PubMed ID: 22777614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.